Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-046803

Chief Development Officer acquired 956 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2023-09-01 Grant or award +478 $33.10 $15,822 5,266 D
Guyer William Chief Development Officer 2023-09-01 Grant or award +478 5,744 D
Loading xslF345X05/ownership.xml…